Forty patients with spinal cord injury (SCI) and heterotopic ossification (HO) were treated
with etidronate and followed after therapy to determine the effects of long-term medication …

A new protocol in management of heterotopic ossification (HO) was evaluated in 46 patients
after spinal cord injury (SCI). A group of 24 paraplegic and 22 tetraplegie patients was …

Sixty-three patients with paralysis secondary to spinal cord injury (SCI) were screened for
heterotopic ossification (HO) by bone scintigraphy 27±14 (mean±SD) days after SCI. There …

The goal of the present study was to use intravenous etidronate in the acute phase of
heterotopic ossification (HO) in an attempt to achieve a high initial drug concentration at the …

Objectives: To determine the effect of indomethacin on the prevention of heterotopic
ossification (HO) following spinal cord injury (SCI). Setting: County Hospital, Miami, Florida …

Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary
report) Page 1 Paraplegia ('976), '4, 146-156 DISODIUM ETIDRONATE IN THE …

Disodium etidronate was used in a clinical trial with four patients to study its effectiveness in
preventing the recurrence of mineralization after surgical removal of heterotopic ossification …

We evaluated the progression of heterotopic ossification (HO) in 17 spinal cord injury
patients by comparing radiographs, quantitative radionuclide bone scans, and serum …

Background: Heterotopic ossification (HO) is a complication of spinal cord injury (SCI)
characterized by formation of ectopic bone. Early diagnosis is critical, but available …

Nine patients who had spinal cord injury and were receiving diphosphonate therapy for
established neurogenic heterotopic ossification in 14 hips were followed up for an average …